Virpax Pharmaceuticals Reports 2022 Year-End Results

March 22, 2023 06:01 AM PDT | By Reuters
Follow us on Google News:

March 22 (Reuters) - Virpax Pharmaceuticals Inc :


* VIRPAX PHARMACEUTICALS INC - FY LOSS PER SHARE $1.85 Source text for Eikon: Further company coverage:


The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.